Showing 9491-9500 of 19185 results for "".
- Revolutionizing ALS Diagnostics: Blood Biomarkers and Genetic Insightshttps://reachmd.com/news/revolutionizing-als-diagnostics-blood-biomarkers-and-genetic-insights/2484249/Combining serum neurofilament light chain (sNfL) with cardiac troponin T (cTnT) improves early diagnostic accuracy for amyotrophic lateral sclerosis (ALS), narrowing diagnostic uncertainty and accelerating diagnostic triage. A
- Study Maps Early Immune Aging and Its Impact on Vaccine Responsehttps://reachmd.com/news/study-maps-early-immune-aging-and-its-impact-on-vaccine-response/2484251/A study published in Nature presents a detailed analysis of how the human immune system changes with age, showing that key aspects of immune aging begin earlier
- AI-Driven Enhancements in Cancer Imaging: Focus on Breast Cancerhttps://reachmd.com/news/ai-driven-enhancements-in-cancer-imaging-focus-on-breast-and-ovarian-cancer/2484236/A mammography-based AI model has been shown to concentrate a disproportionate share of interval breast cancers in its highest-risk strata in a large screening cohort, suggesting image-driven triage could identify women for selective supplemental imaging. The
- Evaluating Telehealth Efficacy in Pelvic Floor Rehabilitation for Stress Urinary Incontinencehttps://reachmd.com/news/evaluating-telehealth-efficacy-in-pelvic-floor-rehabilitation-for-stress-urinary-incontinence/2484237/A recent randomized trial found that telehealth-delivered pelvic floor muscle training (PFMT) produced a clinically meaningful reduction in stress urinary incontinence (SUI)
- Assessing B-GOS's Role in Athletic Recovery and Wellness: New Insights from a 12-Week Trialhttps://reachmd.com/news/assessing-b-goss-role-in-athletic-recovery-and-wellness-new-insights-from-a-12-week-trial/2484239/A 12‑week triple‑blind randomized controlled trial published in Nutrients found no group‑level benefit of daily B‑GOS (3.65 g/day) for general wellbeing or exercise‑induced gastrointestinal (GI) symptoms in recreationally trai
- Breakthrough in Vision Restoration: BCI Retinal Implant Offers New Hope for AMD Patientshttps://reachmd.com/news/breakthrough-in-vision-restoration-bci-retinal-implant-offers-new-hope-for-amd-patients/2484218/A wireless BCI retinal implant restored form central vision in patients with geographic atrophy in a peer-reviewed New England Journal of Medicine trial
- Evolving Cardiovascular Trends in England: Insights from EHR Datahttps://reachmd.com/news/evolving-cardiovascular-trends-in-england-insights-from-ehr-data/2484222/A landmark analysis of linked EHRs from 57 million people in England found that new cardiovascular diagnoses fell during the initial COVID-19 lockdown
- Impact of Lifestyle and Emotional Health on Skin Ulcers: Clinical Insights from Recent Researchhttps://reachmd.com/news/impact-of-lifestyle-and-emotional-health-on-skin-ulcers-clinical-insights-from-recent-research/2484233/A recent MDPI analysis links modifiable lifestyle and emotional factors to higher skin ulcer burden. The investigators performed a cross‑sectional analysis of a single‑center pathology registry
- Study IDs Additional Risk Allele in Allopurinol-Induced Cutaneous Reactions in US Patientshttps://reachmd.com/news/study-ids-additional-risk-allele-in-allopurinol-induced-cutaneous-reactions-in-us-patients/2484235/A recently published genetic association study has identified HLA-A34:02 as an independent allele significantly associated with severe cutaneous adverse reactions (SCARs) to allopurinol in a US-based cohort. Researchers from
- Advancements in Image-Guided Bleomycin Electrosclerotherapy for Vascular Anomalieshttps://reachmd.com/news/advancements-in-image-guided-bleomycin-electrosclerotherapy-for-vascular-anomalies/2484107/Bleomycin electrosclerotherapy (BEST) is a validated, minimally invasive option for treatment‑resistant vascular anomalies, offering improved lesion reduction with an acceptable safety profile, according to a recent review in